Chung, Byung Ha <br/><br/>
Clinical outcome in patients with chronic antibody-mediated rejection treated with and without rituximab and intravenous immunoglobulin combination therapy.  [electronic resource] 

 -  Transplant immunology  Sep 2014 
 - 140-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-5492 
<br/><br/><label>Standard No.: </label>10.1016/j.trim.2014.08.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antibody-Dependent Cell Cytotoxicity--drug effects<br/>Chronic Disease<br/>Creatinine--urine<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate--drug effects<br/>Graft Rejection--drug therapy<br/>Graft Survival--drug effects<br/>Humans<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Kidney--drug effects<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Rituximab<br/>Treatment Outcome